Global In Vitro Diagnostics (IVD) Market Report: 2012 Edition

March 1, 2013 - PRLog -- In-vitro diagnostic (IVD) tests are performed to examine specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information concerning physiological or pathological state, or concerning congenital abnormality. IVD accounts for a major share of the global diagnostics market, and the same continues to increase irrespective of the unfavorable market conditions such as the recent worldwide economic recession.

On the basis of technology, clinical biochemistry dominates the global IVD market, followed by immunoassays and molecular biology. On the basis of customer segments, clinical laboratories represent the largest segment, followed by point-of-care and research laboratories. Point-of-care customer segment offers diagnostic services at or near the site of the patient. Glucose monitoring recorded the largest share in the point-of-care segment.

Globally, North America, Europe and Japan are the largest IVD markets. In Europe, the largest markets are Germany, France and Italy. India, China and Brazil are the emerging IVD markets which are projected to register high growth in the coming years.

The main drivers of the IVD industry discussed in this report are increasing ageing population, growing diabetic population, high insurance density and low vitamin D penetration. In addition, the report also identifies the key market trends which include significant merger and acquisition activities, coupled with the challenges faced by the industry as a whole.

The global IVD industry is consolidated with the top six players, Roche, Abbott, Seimens, Johnson and Johnson, Danaher and biomerieux, which operate in a  highly competitive environment working in the direction of earning an increased market share.

This report consists of the following sections:

1. IVD: An Overview

1.1 Uses of IVDs
1.2 Market Segments
1.3 IVD Value Chain

2. Global Market Analysis

2.1 Diagnostic Market
2.2 Global IVD Market

2.2.1 Overview
-Market Value
-Major Companies by Segments

2.2.2 IVD Market Segments
-By Technology
-By Customer Segment
-By Region

3. Principal IVD Markets

3.1 European Union
-Overall Market Value
-Market Value by Countries

3.2 China
-Market Overview
-Market Value

3.3 India
-Market Overview
-Market Value

3.4 Brazil
-Market Overview
-Market Value

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Ageing Population
4.1.2 Diabetic Population
4.1.3 Increasing Insurance Density
4.1.4 Low Penetration of Vitamin D Tests

4.2 Key Trends

4.2.1 Growing Market for Point of Care Diagnostics
4.2.2 Emerging Korean Molecular Diagnostics Business
4.2.3 Mergers and Acquisitions

4.3 Challenges

4.3.1 Stringent Regulations

5. IVD Market - Competitive Landscape

5.1 Worldwide Competition

5.1.1 Competition in Brazil

5.2 Competition by Segments
-Immunoassay
-Molecular Biology
-Microbiology

5.3 Competition by Company Performance
-Revenues
-Operating Margin
-R&D Expenditure

6. Company Profiles
6.1 Roche Holdings AG
6.2 Siemens AG
6.3 Abbott Laboratories

7. Market Outlook

7.1 Market Forecast
7.2 Forecast Methodology

7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis

List of Charts

IVD Market – Segments by Technology
IVD Market – End Users
IVD Value Chain Analysis in Medical Application
Global Diagnostics Market (2005-2012E)
Global IVD Market (2006-2011)
Global IVD Market by Technology (2011)
Global IVD Market by Customer Segment (2011)
Global Point-of-care Market by Major Segments (2009-2011)
Global IVD Market by Region (2011)
IVD Market in the European Union (2007-2011)
European IVD Market Revenues (2006-2011)
IVD Market in the Europe – by Countries (2011)
China IVD Market Revenues (2000-2011)
India IVD Market Revenues (2001-2011)
Brazil IVD Market Revenues (2003-2012)
Ageing Population Worldwide, age>65 (2005-2015)
World Population with Diabetes, Age Group 20-79 years (2006-2012)
Global Insurance Density (2004-2011)
Global vitamin D Market (2007-2011)
Vitamin D Tests Penetration by Region (2011E)
The US Vitamin D Tests Market (2011E-2015E)
Europe Vitamin D Tests Market (2011E-2015E)
Brazil Vitamin D Tests Market (2011E-2015E)
No. of IVD M&A’s per year (2009-2012)
No. of M&A Deals According to Primary IVD Target Company (2009-2012)
No. of IVD Partnership Deals by Type (2009-2012)
Global IVD Market – Share Breakdown by Company (2011)
IVD Players in Brazil (2011)
Immunoassays Market Share (2012E)
Number of Tests Available on Main Immunoassays Platform (2011)
Molecular Biology Market Share (2012E)
Microbiology Market Share (2012E)
Sales of IVD Players (2011)
Operating Margins of the IVD Players (2011)
R&D Spending of Major Pure IVD Players (2011)
Roche Revenue – Share by Segments (2011)
Roche Holdings Revenue and Net Income (2007-2011)
Siemens AG’s Revenue Share by Business Segments (2011)
Siemens AG’s Revenues and Net Income (2008-2012)
Abbott Laboratories Revenue – Share by Segments (2011)
Abbott Laboratories Revenue (2007-2011)
Global In Vitro Diagnostics Market (2010-2015E)

List of Tables

IVD Market Key Players-by Segments
Global IVD Market by Technology (2005-2011)
Country-wise Division of European IVD Market (2011)
Main M&A Deals in the IVD Sector (2009-2012)
Dependent & Independent Variables (2005–2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

For further details, kindly visit: http://www.konceptanalytics.com/reportDetail.aspx?reportI...